- Display 15 Products per page
Published: November 1, 2008 | Price: $1,990.00 – $2,000.00
This report takes a bold look into the world glucose testing, ten years from now. It is not an exercise in crystal ball gazing. Rather, in this report, Kalorama offers a calculated look into the future, based on events taking place in the present. The report offers a quantitative assessment of specific markets, worldwide, in US dollars for 2007 to 2012. With the reported growing epidemic of diabetes, worldwide, it is widely held that glucose self testing and diabetes management...Published: May 1, 2009 | Price: $250.00 – $1,600.00
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...Published: September 7, 2017 | Price: $2,400.00 – $4,800.00
This report takes a look at both prevention procedures such as sterilization and surface area disinfection and testing such as molecular tests and immunoassays. Infection control in healthcare facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of healthcare is known as a nosocomial, or hospital acquired, infection. What...Published: May 19, 2020 | Price: $5,000.00 – $10,000.00
Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, hemoglobin (automated, manual), sedimentation rate, reticulocyte count, white blood cell (WBC) count, platelet count and analysis, and red blood...Published: April 6, 2023 | Price: $3,750.00 – $7,000.00
SKU 23-708: There is a nearly $10 billion-dollar market for hematology and coagulation IVD testing. Increasingly growth is driven by new technologies, the aging population, and the demand for decentralized testing. This report provides: Market sizing for Hematology IVD and Coagulation IVD Markets for Decentralized and Lab-based Segments. Forecasts to 2027 Market Share Country Markets for Hematology (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States) Country Markets for Coagulation (Australia, Brazil, Canada, China,...Published: September 1, 2018 | Price: $2,500.00 – $5,000.00
Hepatitis Testing Markets This report, Hepatitis Testing Markets, includes Hepatitis Immunoassay Market, 2016 - 2021 Hepatitis Molecular Testing Market, 2016 -2021 Hepatitis Point of Care Markets, 2016-2021 Molecular Testing Market by Type (C, B, A and Others) Key Trends in the Market Geographic Breakout of Market (US, ROW) Company Profiles HCV in particular is a driver of sales in this market. While HCV infections are increasingly caught and treated among baby boomers (a fact easily observable in Medicare billings), U.S....Published: May 20, 2022 | Price: $5,000.00 – $10,000.00
This report, Histology and Cytology IVD Market Update, provides competitive analysis of the histology/cytology market from 2021 to 2026. Histology/cytology has been a mainstay of the pathological lab, providing information about cells, tissues and organs. A variety of diseases can be identified with a histopathological examination. Physicians rely on information from the pathologist as to whether there is cancer present or other disease. The physician bases their treatment and prognosis on the pathological information obtained. Technological advancements have increased the...Published: October 25, 2017 | Price: $3,600.00 – $7,200.00
HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) Kalorama Information’s HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) provides market size and growth of the global HIV testing market, including: Global HIV Testing Market, 2015-2022 (in millions at manufacturer level) Global HIV Testing Market Share Percent by Test Category, 2017 (%; Lab-based, Molecular, POC) Global HIV Testing Market Share Percent by Test Category, 2022 (%; Lab-based, Molecular, POC) The three categories of the global HIV testing market – lab-based immunoassay HIV testing,...Published: December 14, 2015 | Price: $175.00 – $350.00
Hologic: Company Profile Hologic: Company Profile examines this leading developer, manufacturer, and supplier of premium diagnostic products, medical imaging systems and surgical products. The company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. Hologic, Inc. is a leading developer, manufacturer and supplier of products dedicated to women’s health. Hologic provides products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm...Published: July 1, 2011 | Price: $150.00 – $300.00
A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a nosocomial infection (or more generically healthcare-associated infections). The industry has responded with a variety of testing and treatment products. This report, Hospital-Acquired Infections: Diagnostic Markets and Testing Developments,...Published: December 6, 2017 | Price: $1,200.00 – $2,400.00
Human Microbiome Applications in IVD and Other Healthcare Human Microbiome Applications in IVD and Other Healthcare examines the growing interest in the human microbiome in in vitro diagnostics and other healthcare applications. This report notes IVD company interest in the microbiome, including selected microbiome-based tests, including selected molecular tests; microbiome-based diagnostic biomarkers; and precision or personalized medicine approaches to the microbiome. Human Microbiome Applications in IVD and Other Healthcare notes pharmaceutical company interest in the microbiome as well. Discussed are...Published: September 6, 2017 | Price: $3,600.00 – $7,200.00
Immunoassay Markets (Infectious Disease, Tumor Markers, Thyroid, Allergy, Drugs of Abuse, Therapeutic Drug Monitoring, Others) This report, from Kalorama Information, the premier market research publisher in in vitro diagnostics, features the following market data: Global Immunoassay Market, 2017-2021 Historical Market 2014-2016 ELISA Markets Radioimmunoassay Markets Lab-baded Immuonassay Markets POC Immumonassays Infectious Disease Immunoassays - (Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease) Tumor Marker Immunoassays Thyroid Metabolic and Other Hormone Immunoassays Therapeutic Drug Monitoring Immunoassays Drugs of Abuse Immunoassays...Published: September 22, 2023 | Price: $6,000.00 – $12,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information’s In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests and the future potential. In the process, pricing analysis is also performed. This report...Published: June 1, 2011 | Price: $150.00 – $300.00
There is much discussion about emerging markets in in vitro diagnostics, especially the BRIC nations - Brazil, Russia, India and China. Which companies have been successful in these markets and how have they accomplished it? What kind of realistic growth can marketers expect by selling products in these areas? This report is intended to provide an overview of trends and developments in the IVD industry as it applies to emerging markets and the BRIC countries in particular. A Realistic Look...Published: March 27, 2024 | Price: $5,000.00 – $10,500.00
Diagnostic testing has become a fundamental aspect of healthcare, aiding physicians in diagnosing conditions and determining treatments. Despite a decline in COVID-19 testing affecting total revenues, core diagnostic segments have generally experienced growth. Factors such as new products, changes in global health spending, regulatory shifts, and disease trends contribute to a constantly changing market, yet one that remains resilient. Key growing segments attracting industry attention include next-generation sequencing (NGS), personalized medicine, and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular...